Jazz Pharmaceuticals (JAZZ)
240.06
0.00 (0.00%)
Upcoming Events
Latest Headlines
Jazz Pharmaceuticals to present 21 abstracts at SLEEP 2026 conference
June 4, 2026 7:45 AM - StreetInsider
Jazz Pharmaceuticals to Present Comprehensive Data at SLEEP 2026 Highlighting Broad Treatment Effects of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for People with Narc
June 4, 2026 7:45 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Jun 01 Filed by: COZADD BRUCE C
June 3, 2026 5:10 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
June 1, 2026 4:14 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Patil Neena M
June 1, 2026 4:10 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Pearce Samantha
June 1, 2026 4:08 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 28 Filed by: Mulligan Seamus
June 1, 2026 4:03 PM - SEC Filing
Form PRE 14A Jazz Pharmaceuticals For: Jul 23
May 29, 2026 4:12 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: May 25
May 29, 2026 4:05 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Patil Neena M
May 28, 2026 5:09 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Pearce Samantha
May 28, 2026 5:04 PM - SEC Filing
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
May 28, 2026 4:07 PM - StreetInsider
Form 4 Jazz Pharmaceuticals For: May 22 Filed by: Winningham Rick E
May 27, 2026 6:13 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: May 22 Filed by: McSharry Heather Ann
May 27, 2026 6:07 PM - SEC Filing
Jazz Pharmaceuticals publishes cancer trial results in medical journal
May 27, 2026 5:00 PM - StreetInsider
Phase 3 HERIZON-GEA-01 Results Published in The New England Journal of Medicine Show Durable and Consistent Survival Benefit with Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally
May 27, 2026 5:00 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $253 at Barclays
May 27, 2026 2:26 AM - StreetInsider
Form 144 Jazz Pharmaceuticals Filed by: McSharry Heather Ann
May 22, 2026 4:27 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Winningham Rick E
May 22, 2026 4:13 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $301 at Piper Sandler
May 22, 2026 7:32 AM - StreetInsider
Bernstein SocGen Group Starts Jazz Pharmaceuticals (JAZZ) at Market Perform
May 21, 2026 4:24 PM - StreetInsider
JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms
May 20, 2026 3:10 PM - StreetInsider
JPMorgan Reinstates Jazz Pharmaceuticals (JAZZ) at Overweight
May 20, 2026 4:30 AM - StreetInsider
UBS Upgrades Jazz Pharmaceuticals (JAZZ) to Buy
May 19, 2026 4:14 AM - StreetInsider
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
May 12, 2026 4:15 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $245 at Morgan Stanley
May 7, 2026 9:01 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $265 at Wells Fargo
May 6, 2026 8:46 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $275 at TD Cowen
May 6, 2026 8:18 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $234 at Barclays
May 6, 2026 7:03 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $252 at Baird
May 6, 2026 6:43 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) PT Raised to $258 at RBC Capital
May 6, 2026 5:24 AM - StreetInsider
Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 172c; offers guidance
May 5, 2026 4:31 PM - StreetInsider
Form 4 Jazz Pharmaceuticals For: May 01 Filed by: COZADD BRUCE C
May 5, 2026 4:27 PM - SEC Filing
Form 10-Q Jazz Pharmaceuticals For: Mar 31
May 5, 2026 4:10 PM - SEC Filing
Form 8-K Jazz Pharmaceuticals For: May 05
May 5, 2026 4:08 PM - SEC Filing
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
May 5, 2026 4:05 PM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
May 1, 2026 3:45 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Jefferies
April 30, 2026 1:31 PM - StreetInsider
Form SCHEDULE 13G Jazz Pharmaceuticals Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 30, 2026 11:19 AM - SEC Filing
FDA accepts Jazz Pharmaceuticals filing for cancer drug combination
April 27, 2026 7:45 AM - StreetInsider
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Me
April 27, 2026 7:45 AM - PR NewsWire
Form 10-K/A Jazz Pharmaceuticals For: Dec 31
April 24, 2026 4:10 PM - SEC Filing
Jazz Pharmaceuticals (JAZZ) PT Raised to $255 at Needham
April 24, 2026 8:44 AM - StreetInsider
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
April 21, 2026 4:15 PM - PR NewsWire
Jazz Pharmaceuticals to Present Data at ASCO 2026 Highlighting Advancements for Ziihera® (zanidatamab-hrii) in Gastroesophageal Adenocarcinoma and Zepzelca® (lurbinectedin)
April 21, 2026 4:05 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $225 at Barclays
April 20, 2026 4:00 AM - StreetInsider
Raymond James Starts Jazz Pharmaceuticals (JAZZ) at Outperform
April 9, 2026 4:26 PM - StreetInsider
Jazz Pharmaceuticals to Present Research on Epidiolex® (cannabidiol) and Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution at the 2026 American Academy of Neurology Annual Me
April 9, 2026 7:45 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Apr 01 Filed by: COZADD BRUCE C
April 3, 2026 5:10 PM - SEC Filing
Jazz Pharmaceuticals to Participate in Needham Virtual Healthcare Conference
April 1, 2026 4:15 PM - PR NewsWire
Form 144 Jazz Pharmaceuticals Filed by: COZADD BRUCE C
April 1, 2026 4:04 PM - SEC Filing
Form SCHEDULE 13G/A Jazz Pharmaceuticals Filed by: VANGUARD GROUP INC
March 27, 2026 10:21 AM - SEC Filing
American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education
March 24, 2026 1:50 PM - PR NewsWire
Jazz Pharmaceuticals (JAZZ) PT Raised to $232 at Piper Sandler
March 19, 2026 8:32 AM - StreetInsider
RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
March 18, 2026 9:21 AM - StreetInsider
Jazz Pharmaceuticals to Present Compelling Clinical and Pre-Clinical Data Advancing Oncology Research at AACR 2026
March 18, 2026 7:44 AM - PR NewsWire
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: COZADD BRUCE C
March 9, 2026 5:31 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Johnson Philip L
March 9, 2026 5:27 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Henderson Mary Elizabeth
March 9, 2026 5:25 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Pearce Samantha
March 9, 2026 5:23 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Iannone Robert
March 9, 2026 5:21 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Carr Patricia
March 9, 2026 5:16 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: GALA RENEE D
March 9, 2026 5:10 PM - SEC Filing
Form 4 Jazz Pharmaceuticals For: Mar 05 Filed by: Patil Neena M
March 9, 2026 5:07 PM - SEC Filing
Form 144 Jazz Pharmaceuticals Filed by: Carr Patricia
March 9, 2026 4:27 PM - SEC Filing
Barclays Reiterates Overweight Rating on Jazz Pharmaceuticals (JAZZ)
March 9, 2026 4:01 PM - StreetInsider
Full Article List
